clinical trial · NCT04573660
Abbott Vascular Medical Device Registry
Abbott Medical Devices·—·recruiting·n = 3,784
Acute Myocardial InfarctionRestenoses, CoronaryCoronary Artery LesionsVenous EmbolismArterial EmbolismCoronary and peripheral stentsPacing cathetersVascular plugsMeasurement and imaging (FFR and OCT)Peripheral dilatation cathetersCoronary dilatation cathetersCoronary and peripheral guidewiresVessel closure/compression devices
brief summary
The AV-MDR is a prospective, non-randomized, open-label, multi-center registry. The purpose of the AV-MDR study is to proactively collect and evaluate clinical data on the usage of the devices in scope within their intended use with the aim of confirming safety and performance throughout their expected lifetime, ensuring the continued acceptability of identified risks, detecting emerging risks on the basis of factual evidence, ensuring the continued acceptability of the benefit-risk ratio, and identifying possible systematic misuse or off-label usage such that the intended use can be verified as appropriate.
started
Oct 25, 2020
primary completion
Nov 1, 2030
completion
Nov 1, 2031
last updated
Jul 3, 2025
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol